首页|期刊导航|Journal of Biomedical Research|One-year outcomes of a single bolus r-SAK before primary PCI for STEMI:Follow-up of the OPTIMA-5 study
One-year outcomes of a single bolus r-SAK before primary PCI for STEMI:Follow-up of the OPTIMA-5 study
Chen Li Jie Yu Tian Wu Qingxia Lin Rui Hua Zihang Zhong Yule Li Kun Liu Li Zhu Naiquan Yang Xin Chen Xiaoyan Wang Xin Zhao Jun Jiang Bo Zhao Xiwen Zhang Pengsheng Chen Tong Wang Yi Xu Gaoyong Liao Liang Yuan Bo Chen Zhihui Xu Xiaoxuan Gong Wenhao Zhang Chunyue Tan Lei Xu Qiang Huang Jianling Bai John WEikelboom Chunjian Li
Journal of Biomedical Research2025,Vol.39Issue(6):P.611-621,I0014-I0021,19.
Journal of Biomedical Research2025,Vol.39Issue(6):P.611-621,I0014-I0021,19.DOI:10.7555/JBR.39.20250043
One-year outcomes of a single bolus r-SAK before primary PCI for STEMI:Follow-up of the OPTIMA-5 study
摘要
关键词
recombinant staphylokinase/myocardial infarction/thrombolysis/percutaneous coronary intervention分类
医药卫生引用本文复制引用
Chen Li,Jie Yu,Tian Wu,Qingxia Lin,Rui Hua,Zihang Zhong,Yule Li,Kun Liu,Li Zhu,Naiquan Yang,Xin Chen,Xiaoyan Wang,Xin Zhao,Jun Jiang,Bo Zhao,Xiwen Zhang,Pengsheng Chen,Tong Wang,Yi Xu,Gaoyong Liao,Liang Yuan,Bo Chen,Zhihui Xu,Xiaoxuan Gong,Wenhao Zhang,Chunyue Tan,Lei Xu,Qiang Huang,Jianling Bai,John WEikelboom,Chunjian Li..One-year outcomes of a single bolus r-SAK before primary PCI for STEMI:Follow-up of the OPTIMA-5 study[J].Journal of Biomedical Research,2025,39(6):P.611-621,I0014-I0021,19.基金项目
supported by the National Natural Science Funding of China(Grant No.82170351) (Grant No.82170351)
the Special Fund for Key R&D Plans(Social Development)of Jiangsu Province(Grant No.BE2019754) (Social Development)
Kanion Pharmaceutical Group,Lianyungang,Jiangsu,China。 ()